Evidence map›Paper›PMID 37864151›Full record

ArticleBMC cancer2023

Development of a well-defined tool to predict the overall survival in lung cancer patients: an African based cohort.

Hassan Abdelilah Tafenzi, Farah Choulli, Ganiou Adjade, Anas Baladi, Leila Afani, Mohammed El Fadli, Ismail Essaadi, Rhizlane Belbaraka

Abstract read
In one paragraph

Article in BMC cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hassan Abdelilah TafenziMedical Oncology Department, Mohammed VI University Hospital of Marrakech, Marrakech, Morocco. hassanabdelilah.tafenzi@gmail.com.
Farah ChoulliMedical Oncology Department, Mohammed VI University Hospital of Marrakech, Marrakech, Morocco.
Ganiou AdjadeMedical Oncology Department, Mohammed VI University Hospital of Marrakech, Marrakech, Morocco.
Anas BaladiMedical Oncology Department, Mohammed VI University Hospital of Marrakech, Marrakech, Morocco.
Leila AfaniMedical Oncology Department, Mohammed VI University Hospital of Marrakech, Marrakech, Morocco.
Mohammed El FadliMedical Oncology Department, Mohammed VI University Hospital of Marrakech, Marrakech, Morocco.
Ismail EssaadiFaculty of Medicine and Pharmacy, Biosciences and Health Laboratory, Cadi Ayyad University, Marrakech, Morocco.
Rhizlane BelbarakaMedical Oncology Department, Mohammed VI University Hospital of Marrakech, Marrakech, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNomogram is a graphic representation containing the expressed factor of the mathematical formula used to define a particular phenomenon. We aim to build and internally validate a nomogram to predict overall survival (OS) in patients diagnosed with lung cancer (LC).

methodsWe included 1200 LC patients from a single institution registry diagnosed from 2013 to 2021. The independent prognostic factors of LC patients were identified via cox proportional hazard regression analysis. Based on the results of multivariate cox analysis, we constructed the nomogram to predict the OS of LC patients.

resultsWe finally included a total of 1104 LC patients. Age, medical urgency at diagnosis, performance status, radiotherapy, and surgery were identified as prognostic factors, and integrated to build the nomogram. The model performance in predicting prognosis was measured by receiver operating characteristic curve. Calibration plots of 6-, 12-, and 24- months OS showed optimal agreement between observations and model predictions.

conclusionWe have developed and validated a unique predictive tool that can offer patients with LC an individual OS prognosis. This useful prognostic model could aid doctors in making decisions and planning therapeutic trials.

Indexed as

Lung NeoplasmsNomogramsBlack PeopleCalibrationDecision MakingHumansPrognosisSEER ProgramSurvival AnalysisLung cancerNomogramOverall survival

Identifiers

PMID37864151
PMCPMC10589978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.